Aug 2026· Microorganisms· Vol 14, pp. 1754· 0 citations· 46 references
Medicine
TL;DR
The results suggest that the tested probiotics could prevent colonization of the skin by relevant pathogens through barrier and interference mechanisms (mainly exclusion), suggesting a potential use in the future conventional therapies of skin disorders.
Abstract
Acne vulgaris is a highly prevalent inflammatory skin condition involving the interaction between skin microbes and host immunity, which lead with the changes in composition and activities of the skin microbiota disturbing its homeostasis. Several probiotic strains have been tested for their anti-pathogenic activity against the main acne-responsible bacteria, their capacity to contrast pathogenic adhesion to HaCaT cells and the in vitro down-regulation of innate immunity. To investigate whether probiotics have direct effects on the growth of Cutibacterium acnes, Staphyloccoccus aureus, Streptococcus pyogenes and Streptococcus epidermidis, the antimicrobial activity of six probiotics was analyzed by two different methods (modified cross-streak and agar well diffusion). The in vitro blockage of pathogens’ adherence by the probiotic strains to HaCaT cells was also investigated, under three possible mechanisms: exclusion by adhered probiotics, displacement of adhered pathogens and competition for receptor sites. The inflammatory response was evaluated by the Luminex approach, targeting a selection of innate immune markers in the HaCaT cell culture media. All probiotic strains showed anti-pathogenic activity against the pathogens tested. The inhibition result on HaCaT cells highlights a significant (p < 0.05) competition of all probiotics against all pathogens. Each pathogenic strain alone led to an up-regulation of innate immune markers, while restoration of the microbiome diversity by probiotics presence may suppress inflammation via down-regulation of innate immunity. The results suggest that the tested probiotics could prevent colonization of the skin by relevant pathogens through barrier and interference mechanisms (mainly exclusion), suggesting a potential use in the future conventional therapies of skin disorders.
Atopic dermatitis (AD) is a prevalent chronic inflammatory skin disease characterized by epidermal barrier dysfunction, type 2 immune skewing, and microbiome dysbiosis. Although live probiotics can modulate the gut-skin axis, their clinical use is limited by variable efficacy and safety concerns. Probiotic extracellula...
V. Wayal, Mey-Fann Lee, Jiu-Yao Wang et al.· Clinical reviews in allergy...· 1 citation
Test the hypothesis that plant extracts trigger the gentle release of staphylococcal bioactive components that can modulate innate immunity and presents V. opulus extracts as the triggers to release bioactive components from S. aureus cells, able to target innate immunity against staphylococci, which may be used in the...
This review synthesizes current evidence on host immune responses to bacteria, their roles in the development and progression of periodontitis, and emerging immunomodulatory therapeutic strategies designed to restore periodontal homeostasis. Periodontitis develops through interactions between a dysbiotic bacterial comm...
Valle Miranda, Mel de Araujo Teixeira, J. G. Souza et al.· Einstein· 0 citations
The possibility of multiple positive clinical effects of Bacillus clausii in patients for the prevention and treatment of antibiotic-associated diarrhea in adults and children, eradication therapy of Helicobacter pylori infection, rotavirus infection in children, irritable bowel syndrome in children and adults, recurre...
Background Candida species are among the most important opportunistic fungal pathogens responsible for superficial mucosal infections and life-threatening invasive candidiasis, particularly in immunocompromised individuals. The increasing prevalence of antifungal resistance, biofilm-associated tolerance, and the emerge...
Taparia Saloni, N. Chaithra, S. Umamaheshwari· Frontiers in Cellular and In...· 0 citations
Development of a microbiological therapeutic and prophylactic drug based on lactic acid and propionic acid bacteria (probiotics) to increase the resistance of agricultural animals to diseases is proposed.
Z. Sagidoldina, L. Zhailybaeva, E. Bukenova et al.· Brazilian Journal of Biology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.